Showing results (261-270 of 780) with videos related to

Sort By:
Pageof 78
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1985
[Antitumor effect of etoposide and its analogs]H Kuramochi, K Okamoto, K Nishikawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1992
[Etoposide and cisplatin combination chemotherapy in a patient with small cell lung carcinoma under artificial hemodialysis]S Ono, T Miyazaki, K Nishikawa, et al.
Japanese Journal of Pharmacology|January 1, 1990
Antagonistic action of AA-2414 on thromboxane A2/prostaglandin endoperoxide receptor in platelets and blood vesselsY Imura, Z Terashita, Y Shibouta, et al.
Molecular Pharmacology|December 1, 1989
H-7, a protein kinase C inhibitor, inhibits phorbol ester-caused ornithine decarboxylase induction but fails to inhibit phorbol ester-caused suppression of epidermal growth factor binding in primary cultured mouse epidermal cellsT Nakadate, S Yamamoto, E Aizu, et al.
Auris, Nasus, Larynx|January 1, 1992
Evaluation of the Pharmacia CAP System, a new test for allergic diagnosis (cedar pollinosis)K Nishikawa, M Nishikawa, N Teramoto, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1987
CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivoZ Terashita, Y Imura, M Takatani, et al.
Thrombosis Research|May 15, 1993
Inhibitory effect of TCV-309, a novel platelet activating factor (PAF) antagonist, on endotoxin-induced disseminated intravascular coagulation in rats: possible role of PAF in tissue factor generationM Kawamura, Z Terashita, Y Imura, et al.
[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai|June 1, 1995
[A case of successful surgical retrieval of the intracoronary interlocked Palmaz-Schatz stent]T Misumi, K Nishikawa, T Gotoh, et al.
Drugs Under Experimental and Clinical Research|January 1, 1995
Effects of delapril on stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive ratsY Inada, M Ojima, K Itoh, et al.
Thrombosis Research|July 1, 1995
Beneficial effect of CV-4151 (Isbogrel), a thromboxane A2 synthase inhibitor, in a rat middle cerebral artery thrombosis modelY Imura, Y Kiyota, Y Nagai, et al.
Pageof 78